StonvexLoading…
StonvexStonvexStonvexCore line items from CWK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $10.29B | $9.45B | $9.49B | $10.11B |
Operating Income | $452.50M | $338.90M | $205.60M | $535.10M |
Net Income | $88.20M | $131.30M | $-35.40M | $196.40M |
EPS (Diluted) | $0.38 | $0.56 | $-0.16 | $0.86 |
Total Assets | $7.68B | $7.55B | $7.77B | $7.95B |
Total Liabilities | $5.72B | $5.79B | $6.10B | $6.29B |
Cash & Equivalents | $784.20M | $793.30M | $767.70M | $644.50M |
Free Cash Flow OCF − CapEx | $293.00M | $167.00M | $101.20M | $-1.60M |
Shares Outstanding | 231.70M | 229.70M | 227.28M | 225.78M |